Latest filing published 18 Feb 2021 for Mydecine Innovations Group Inc., €263k.
Michael Connolly appears in our data through filings on Mydecine Innovations Group Inc. shares, published by SEDI. The record holds 4 filings, for trades running from 15 January 2021 to 18 February 2021.
On the market, this insider has only sold: 4 sales, €783k in total.
On 18 February 2021 came the latest disclosure, an open-market sale for €263k in Mydecine Innovations Group Inc. Filings reach the SEDI feed a median of 2 days after the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations